Boston, MA - Being overweight or obese does not lead to improved survival among patients with type 2 diabetes. The large-scale study led by Harvard School of Public Health (HSPH) researchers refutes previous studies that have suggested that, for people with diabetes, being overweight or obese could lead to lower mortality for people compared with normal-weight persons—the so-called "obesity paradox."
The study appears in the January 16 issue of the New England Journal of Medicine.
"These data dispel the notion that being overweight or obese confers survival advantage among diabetic patients," said Frank Hu, professor of nutrition and epidemiology at HSPH and senior author of the study. "Clearly, weight management is an important therapeutic strategy for overweight or obese individuals with type 2 diabetes."
The researchers analyzed data from 8,970 women in the Brigham and Women's Hospital-based Nurses' Health Study (NHS) and 2,457 men in the Health Professionals Follow-up Study (HPFS) with type 2 diabetes. They calculated participants' body-mass index (BMI) shortly before the diagnosis of diabetes and excluded participants reporting a history of diabetes at baseline or cardiovascular disease or cancer before they were diagnosed with diabetes; underweight participants were also excluded. Participants were followed for a maximum of 36 years (NHS) and 26 years (HPFS). A total of 3,083 deaths were recorded.
The results showed a positive association between BMI at the time of diabetes diagnosis and risk of death from all causes. The lowest risk of death was observed among people of normal weight. Lower mortality was not observed among overweight or obese participants, that is, the findings showed no benefit from being overweight or obese. In addition, there was a dose-response relationship between BMI and mortality among people who had never smoked, such that a higher BMI just prior to diabetes diagnosis was associated with a higher risk of death. This trend was less pronounced among smokers because smokers tend to be leaner than nonsmokers but they have increased risk of death.
The results contradict some previous studies that had shown a benefit-lower risk of death-for patients with chronic illnesses, such as type 2 diabetes, and excess adiposity. The authors cite several limitations in those studies, including small sample sizes, measurement of BMI years after diabetes diagnosis, and failure to properly assess biases from smoking and undiagnosed chronic diseases, which often lead to weight loss.
"In most studies of BMI and mortality, 'normal weight' reference groups are comprised of not only those who are lean and healthy, but also smokers as well as people with existing or undiagnosed illnesses. This can skew the relationship between weight and mortality to make the normal weight group seem worse off than the overweight and obese groups. As a result, people with higher BMIs might have artificially improved survival rates," said Deirdre Tobias, lead author of the paper and a research fellow in the Department of Nutrition at HSPH. "After carefully controlling for many of these factors in our analysis, we observed that excess weight in those with diabetes was not advantageous for survival. These findings underscore the importance of addressing methodological biases in the analysis of BMI and mortality."
The study was supported by National Institutes of Health grants (UM1 CA167552, UM1 CA176726, P01 CA87969, R01 HL034594, P01 CA055075, DK58845, CA55075, CA87969, HL34594, P30 DK46200, and 1U54CA155626-01) and the American Diabetes Association (7-12-MN-34).
Visit the HSPH website for the latest news, press releases and multimedia offerings.
"Body-Mass Index and Mortality among Adults with Incident Type 2 Diabetes," Deirdre K. Tobias, An Pan, Chandra L. Jackson, Eilis J. O'Reilly, Eric L. Ding, Walter C. Willett, JoAnn E. Manson, Frank B. Hu, NEJM, 370:233-244, Jan. 16, 2014
About Harvard School of Public Health
Harvard School of Public Health brings together dedicated experts from many disciplines to educate new generations of global health leaders and produce powerful ideas that improve the lives and health of people everywhere. As a community of leading scientists, educators, and students, we work together to take innovative ideas from the laboratory and the classroom to people's lives—not only making scientific breakthroughs, but also working to change individual behaviors, public policies, and health care practices. Each year, more than 400 faculty members at HSPH teach 1,000-plus full-time students from around the world and train thousands more through online and executive education courses. Founded in 1913 as the Harvard-MIT School of Health Officers, the School is recognized as America's first professional training program in public health.
HSPH on Twitter: http://twitter.com/HarvardHSPH HSPH on Facebook: http://www.facebook.com/harvardpublichealth HSPH on You Tube: http://www.youtube.com/user/HarvardPublicHealth HSPH home page: http://www.hsph.harvard.edu
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.